487 related articles for article (PubMed ID: 29416331)
1. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
[TBL] [Abstract][Full Text] [Related]
2. Poly (butylene adipate-co-butylene terephthalate) nanoparticles prepared by electrospraying technique for docetaxel delivery in ovarian cancer induced mice.
Varshosaz J; Ghassami E; Noorbakhsh A; Jahanian-Najafabadi A; Minaiyan M; Behzadi R
Drug Dev Ind Pharm; 2018 Jun; 44(6):1012-1022. PubMed ID: 29347846
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer.
Ghassami E; Varshosaz J; Minaiyan M; Nasirikenari M; Hoseini SM
Recent Pat Nanotechnol; 2019; 13(1):49-58. PubMed ID: 30488805
[TBL] [Abstract][Full Text] [Related]
5. Trastuzumab-conjugated nanoparticles composed of poly(butylene adipate-
Varshosaz J; Ghassami E; Noorbakhsh A; Minaiyan M; Jahanian-Najafabadi A
IET Nanobiotechnol; 2019 Oct; 13(8):829-833. PubMed ID: 31625523
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
7. Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel.
Yu Z; Li X; Duan J; Yang XD
Int J Nanomedicine; 2020; 15():6737-6748. PubMed ID: 32982230
[TBL] [Abstract][Full Text] [Related]
8. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
9. Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
Xu G; Yu X; Zhang J; Sheng Y; Liu G; Tao W; Mei L
Int J Nanomedicine; 2016; 11():2953-65. PubMed ID: 27382282
[TBL] [Abstract][Full Text] [Related]
10. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
12. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
13. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
[TBL] [Abstract][Full Text] [Related]
16. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
Senthilkumar M; Mishra P; Jain NK
J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
[TBL] [Abstract][Full Text] [Related]
17. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.
Jain S; Spandana G; Agrawal AK; Kushwah V; Thanki K
Mol Pharm; 2015 Nov; 12(11):3871-84. PubMed ID: 26375023
[TBL] [Abstract][Full Text] [Related]
19. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
